You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 23 No. 3, September 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hypnotic Drugs and Their Effectiveness

All-night EEG Studies of Insomniac Subjects

Anthony Kales, MD; Clyde Allen, MA; Martin B. Scharf; Joyce D. Kales, MD

Arch Gen Psychiatry. 1970;23(3):226-232.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE results of previous studies with normal subjects in our laboratory suggested that 1,000 mg of chloral hydrate (Noctec) and 30 mg of flurazepam (Dalmane) were effective in enhancing sleep: chloral hydrate appeared to induce sleep while flurazepam induced and maintained sleep.1

The aim of the present study was to further evaluate the effectiveness of 1,000 mg of chloral hydrate and 30 mg of flurazepam by using insomniac subjects and a two-week drug administration period as part of a 22-night protocol. This contrasted with our previous use of normal subjects and a three-night drug administration period as part of an eight-night schedule. The use of insomniac subjects provides a clear-cut way in which to study the effectiveness of sleep medications. The two-week drug administration period provides not only a more rigorous evaluation of whether drugs produce sleep stage alterations, but also allows for the determination of the length . . . [Full Text PDF of this Article]


Author Affiliations

Los Angeles

From the departments of psychiatry (Dr. A. Kales, Mr. Allen, and Mr. Scharf), psychology (Mr. Allen), and anatomy (Dr. J. Kales), Sleep Research and Treatment Facility, and the Brain Research Institute (Dr. A. Kales), UCLA School of Medicine, Los Angeles.


Footnotes

Accepted for publication April 13, 1970.

Reprint requests to UCLA Sleep Research and Treatment Facility, 760 Westwood Plaza, Los Angeles 90024 (Dr, A, Kales).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.